- Home
- SCLX vs PLG Comparison
SCLX vs PLG Comparison
Compare SCLX & PLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCLX
- PLG
- Stock Information
- Founded
- SCLX 2011
- PLG 2000
- Country
- SCLX United States
- PLG Canada
- Employees
- SCLX N/A
- PLG N/A
- Industry
- SCLX Biotechnology: Pharmaceutical Preparations
- PLG
- Sector
- SCLX Health Care
- PLG
- Exchange
- SCLX Nasdaq
- PLG Nasdaq
- Market Cap
- SCLX 143.6M
- PLG 145.5M
- IPO Year
- SCLX N/A
- PLG N/A
- Fundamental
- Price
- SCLX $0.95
- PLG $1.74
- Analyst Decision
- SCLX Strong Buy
- PLG
- Analyst Count
- SCLX 3
- PLG 0
- Target Price
- SCLX $11.33
- PLG N/A
- AVG Volume (30 Days)
- SCLX 184.3K
- PLG 304.5K
- Earning Date
- SCLX 11-12-2024
- PLG 11-19-2024
- Dividend Yield
- SCLX N/A
- PLG N/A
- EPS Growth
- SCLX N/A
- PLG N/A
- EPS
- SCLX N/A
- PLG N/A
- Revenue
- SCLX $50,833,000.00
- PLG N/A
- Revenue This Year
- SCLX $34.42
- PLG N/A
- Revenue Next Year
- SCLX $12.77
- PLG N/A
- P/E Ratio
- SCLX N/A
- PLG N/A
- Revenue Growth
- SCLX 9.41
- PLG N/A
- 52 Week Low
- SCLX $0.73
- PLG $0.94
- 52 Week High
- SCLX $2.63
- PLG $2.07
- Technical
- Relative Strength Index (RSI)
- SCLX 51.50
- PLG 65.72
- Support Level
- SCLX $0.77
- PLG $1.48
- Resistance Level
- SCLX $1.07
- PLG $1.63
- Average True Range (ATR)
- SCLX 0.09
- PLG 0.11
- MACD
- SCLX 0.02
- PLG 0.01
- Stochastic Oscillator
- SCLX 56.83
- PLG 69.23
About SCLX Scilex Holding Company
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for the relief of pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.
About PLG Platinum Group Metals Ltd. (Canada)
Platinum Group Metals Ltd is the operator of the Waterberg Project, a bulk underground PGM deposit located in South Africa. Waterberg was discovered by Platinum Group and is being jointly developed with Implats, the Japan Oil, Gas and Metals National Corporation (JOGMEC) and Hanwa Co. Ltd. Waterberg has the potential to be a large-scale, low-cost producer of palladium, platinum, rhodium, and gold. Geographically, it operates in Canada and South Africa.